Paper40824641
Biannual Mass Azithromycin Distributions for Preschool Children and Malaria Parasitemia: A Secondary Analysis of the MORDOR Cluster Randomized Trial.
Arzika AM and 16 others. JAMA Netw Open, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Biannual Mass Azithromycin Distributions for Preschool Children and Malaria Parasitemia: A Secondary Analysis of the MORDOR Cluster Randomized Trial. Papers, record 40824641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40824641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Biannual Mass Azithromycin Distributions for Preschool Children and Malaria Parasitemia: A Secondary Analysis of the MORDOR Cluster Randomized Trial.
- PubMed
- Publication types
- Clinical Trial, Phase IV, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Antimalarials | Major topic |
| Azithromycin | Major topic |
| Malaria | Major topic |
| Mass Drug Administration | Major topic |
| Parasitemia | Major topic |
| Child, Preschool | |
| Female | |
| Humans | |
| Infant | |
| Male | |
| Niger |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT02048007 | Mortality Reduction After Oral Azithromycin: Morbidity Study | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT07712263 | Integrating the Guardian Spatial Emanator Within AVENIR II | Background | ClinicalTrials.gov |
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22336792 | Intermittent preventive treatment for malaria in children living in areas with seasonal transmission. | Cochrane Database Syst Rev | 2012 | https://conductscience.org/library/papers/22336792 | PubMed |
| 2 | 30699301 | Effect of Adding Azithromycin to Seasonal Malaria Chemoprevention. | N Engl J Med | 2019 | https://conductscience.org/library/papers/30699301 | PubMed |
| 3 | 25223942 | Optimal seasonal timing of oral azithromycin for malaria. | Am J Trop Med Hyg | 2014 | https://conductscience.org/library/papers/25223942 | PubMed |
| 4 | 38816383 | Plasmodium falciparum infection in humans and mosquitoes influence natural Anopheline biting behavior and transmission. | Nat Commun | 2024 | https://conductscience.org/library/papers/38816383 | PubMed |
| 5 | 29694816 | Azithromycin to Reduce Childhood Mortality in Sub-Saharan Africa. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29694816 | PubMed |
| 6 | 15838784 | A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. | J Infect Dis | 2005 | https://conductscience.org/library/papers/15838784 | PubMed |
| 7 | 10571428 | Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children. | Pediatr Infect Dis J | 1999 | https://conductscience.org/library/papers/10571428 | PubMed |
| 8 | 35337289 | Malaria positivity following a single oral dose of azithromycin among children in Burkina Faso: a randomized controlled trial. | BMC Infect Dis | 2022 | https://conductscience.org/library/papers/35337289 | PubMed |
| 9 | 31167050 | Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31167050 | PubMed |
| 10 | 7564674 | Effects of azithromycin on malariometric indices in The Gambia. | Lancet | 1995 | https://conductscience.org/library/papers/7564674 | PubMed |
| 11 | 31237871 | Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial. | PLoS Med | 2019 | https://conductscience.org/library/papers/31237871 | PubMed |
| 12 | 12693587 | A comparative clinical trial of combinations of dihydroartemisinin plus azithromycin and dihydroartemisinin plus mefloquine for treatment of multidrug resistant falciparum malaria. | Southeast Asian J Trop Med Public Health | 2002 | https://conductscience.org/library/papers/12693587 | PubMed |
| 13 | 29615044 | Simulation models predict that school-age children are responsible for most human-to-mosquito Plasmodium falciparum transmission in southern Malawi. | Malar J | 2018 | https://conductscience.org/library/papers/29615044 | PubMed |
| 14 | 21976574 | Association of mass treatment with azithromycin in trachoma-endemic communities with short-term reduced risk of diarrhea in young children. | Am J Trop Med Hyg | 2011 | https://conductscience.org/library/papers/21976574 | PubMed |
| 15 | 31796025 | Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial. | Malar J | 2019 | https://conductscience.org/library/papers/31796025 | PubMed |
| 16 | 30608051 | Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized Trials. | Am J Trop Med Hyg | 2019 | https://conductscience.org/library/papers/30608051 | PubMed |
| 17 | 29088030 | Annual Versus Biannual Mass Azithromycin Distribution and Malaria Parasitemia During the Peak Transmission Season Among Children in Niger. | Pediatr Infect Dis J | 2018 | https://conductscience.org/library/papers/29088030 | PubMed |
| 18 | 19724043 | Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial. | JAMA | 2009 | https://conductscience.org/library/papers/19724043 | PubMed |
| 19 | 34465327 | Effect of a single dose of oral azithromycin on malaria parasitaemia in children: a randomized controlled trial. | Malar J | 2021 | https://conductscience.org/library/papers/34465327 | PubMed |
| 20 | 27215294 | In Vivo Efficacy and Tolerability of Artesunate-Azithromycin for the Treatment of Falciparum Malaria in Vietnam. | Am J Trop Med Hyg | 2016 | https://conductscience.org/library/papers/27215294 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42623398 | A single dose of azithromycin versus placebo for malaria in infants: A cluster-randomized trial. | PLOS Glob Public Health | 2026 | https://conductscience.org/library/papers/42623398 |
Source PubMed
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| AZITHROMYCIN | CHEMBL529 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL529 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40824641
GET https://conductscience.org/api/papers/v1/40824641/references?page=2